InsidersTradesSigma
申报总数
公司
▲ 买入（6 笔）
▼ 卖出（17 笔）
内部人交易记录
董事已披露买入
6
已披露卖出
17
T+90 胜率
100%
T+90 平均收益
+61.6%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the complete record of transactions filed by Thompson Peter A., 董事. Director active across 7 companies, notably Janux Therapeutics, Inc.. Aggregated, 29 filings have been recorded. Breakdown: 6 buys · 17 sells. Total volume traded: €77.8m. Activity tracked since 17 September 2021. The latest transaction was filed on 7 July 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Thompson Peter A.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报29 总计
85,918 股@ US$44.860.19% mcap13.5% 占其流量Common StockSEC:0000947871-26-000695:0
52,397 股@ US$44.680.11% mcap9.2% 占其流量Common StockSEC:0000947871-26-000459:0
2,948 股@ US$44.520.0063% mcap0.5% 占其流量Common StockSEC:0000947871-26-000459:1
47,814 股@ US$44.510.10% mcap8.4% 占其流量Common StockSEC:0000947871-26-000447:0
235,863 股@ US$44.640.50% mcap41.4% 占其流量Common StockSEC:0000947871-26-000447:1
226,906 股@ US$45.340.49% mcap40.5% 占其流量Common StockSEC:0000947871-26-000447:2
1,890 股@ US$44.570.2% 占其流量Common StockSEC:0000947871-26-000089:0
30,000 股@ US$15.003.6% 占其流量Common StockSEC:0000947871-26-000079:0
33,356 股@ US$44.554.2% 占其流量Common StockSEC:0000947871-25-001095:0
900 股@ US$44.500.1% 占其流量Common StockSEC:0000947871-25-001087:0
94,583 股@ US$44.5412.8% 占其流量Common StockSEC:0000947871-25-001044:0
1,397,684 股@ US$3.5042.1% 占其流量Common StockSEC:0000947871-25-000635:0
372,578 股@ US$20.1339.2% 占其流量Common StockSEC:0000947871-25-000360:0
标准退出：2025年7月2日 (T+90)
3,154,959 股Common StockSEC:0000950170-25-017031:0
83,695 股@ US$13.0011.3% 占其流量Common StockSEC:0000947871-24-000729:0
394,400 股@ US$13.5255.5% 占其流量Common StockSEC:0000947871-24-000721:0
2,416,181 股Common StockSEC:0001626199-24-000096:0
454,545 股@ US$11.0026.5% 占其流量Common StockSEC:0000947871-24-000070:0
标准退出：2024年4月22日 (T+90)
145,251 股@ US$12.7436.5% 占其流量Common StockSEC:0000947871-24-000033:0
162,576 股@ US$19.9663.5% 占其流量Common StockSEC:0000947871-23-001190:0
500,000 股@ US$6.2033.1% 占其流量Common StockSEC:0000947871-23-000914:0
标准退出：2023年11月27日 (T+90)
484,496 股@ US$10.3228.9% 占其流量Common StockSEC:0000947871-22-000973:0
标准退出：2022年12月15日 (T+90)
138,000 股@ US$7.210.036% mcap100.0% 占其流量Common StockSEC:0000947871-22-000628:0
标准退出：2022年8月16日 (T+90)
36,700 股@ US$20.307.7% 占其流量Common StockSEC:0000947871-21-001322:0
108,300 股@ US$19.0021.4% 占其流量Common StockSEC:0000947871-21-001314:0
29 条申报中的 25 条
About Thompson Peter A.
Thompson Peter A. is Administrateur and has filed 29 reports in total. Across the 29 sampled filings, the reported volumes are EUR 24,868,571 of buys and EUR 52,905,880 of sells, over the period from 2021-06-16 to 2026-07-09. The most recent and largest transactions in this sample involve Sionna Therapeutics, Inc., Edgewise Therapeutics, Inc., Janux Therapeutics, Inc. and Corvus Pharmaceuticals, Inc.
